| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +5% |
| 3Y CAGR | -7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +800% |
| 3Y CAGR | -60% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,244.50 -4.60 (0.20%) | 17,105.67 | 25.23 | 5.08 | ||
PfizerPFIZER | ₹3,672.90 -16.00 (0.43%) | 16,879.31 | 22.96 | 4.02 | ||
Natco PharmaNATCOPHARM | ₹782.60 -2.55 (0.32%) | 15,408.99 | 13.46 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,028.00 -73.00 (1.20%) | 15,246.63 | 89.88 | 17.47 |